MAPK1 and non-small cell lung carcinoma: Similarly, the invasive ability of NSCLC cells was decreased when either ERK2 or YAP was depleted, suggesting that ERK2 inhibition suppresses the invasive ability of the NSCLC tumor cells possibly through the Hippo/YAP pathway.